NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
1.645
-0.005 (-0.30%)
At close: Jun 26, 2026, 4:00 PM EDT
1.640
-0.005 (-0.30%)
After-hours: Jun 26, 2026, 7:55 PM EDT
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,366,600
Market Cap
5.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| CNS Pharmaceuticals | 8 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
NXTC News
- 9 days ago - NextCure Transcript: AGM 2026 - Transcripts
- 23 days ago - NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers - GlobeNewsWire
- 25 days ago - NextCure Transcript: KOL event - Transcripts
- 25 days ago - NextCure Press release: KOL event - Filings
- 25 days ago - NextCure Slides: KOL event - Filings
- 25 days ago - NextCure share weakness overdone, says Lucid Capital - TheFly
- 26 days ago - NextCure presents Phase 1 data for SIM0505 in gynecologic cancers - TheFly
- 26 days ago - NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026 - GlobeNewsWire